Published in PLoS One on June 18, 2014
Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy | NCT02505009
Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep (2015) 0.84
Clinical Relevance of HLA Gene Variants in HBV Infection. J Immunol Res (2016) 0.81
Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease. Nat Genet (2016) 0.79
Adaptive evolution of proteins in hepatitis B virus during divergence of genotypes. Sci Rep (2017) 0.75
The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol (2017) 0.75
Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol (2016) 0.75
Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma. World J Gastroenterol (2017) 0.75
Host Genetic Variants in HLA Loci Influence Risk for Hepatitis B Virus Infection in Children. Hepat Mon (2016) 0.75
Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol (2016) 0.75
Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity (2017) 0.75
Correlation of HLA-DP/DQ polymorphisms with transplant etiologies and prognosis in liver transplant recipients. Medicine (Baltimore) (2017) 0.75
Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma. Gastroenterol Res Pract (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med (2004) 10.31
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet (2009) 5.29
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int (2008) 5.25
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology (2010) 3.57
Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients. Hepatology (2013) 2.29
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet (2011) 1.96
A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol (2007) 1.86
Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. J Gastroenterol Hepatol (2007) 1.58
Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age. Am J Gastroenterol (2010) 1.54
Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered (2004) 1.52
Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis (1994) 1.41
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C. Hepatology (2011) 1.35
Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun (2011) 1.32
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. Hepatology (2001) 1.32
Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One (2011) 1.29
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology (2009) 1.27
Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens (1999) 1.26
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol (2012) 1.24
New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet (2013) 1.18
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol (2005) 1.16
Gene organisation, sequence variation and isochore structure at the centromeric boundary of the human MHC. J Mol Biol (1999) 0.98
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst (2003) 0.97
Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PLoS One (2014) 0.97
Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma. J Hepatol (2004) 0.93
Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol (1988) 0.87
HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan. Value Health (2008) 0.86
A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet (2013) 0.85
Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J (2009) 0.83
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study. J Antimicrob Chemother (2013) 0.83
Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma. Am J Trop Med Hyg (1999) 0.83
Geographical distribution of the subtype of hepatitis B surface antigen in Chinese. Gastroenterol Jpn (1977) 0.83
Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol (2002) 0.79
The prevalence of anti-HCV among Chinese voluntary blood donors in Taiwan. Transfusion (1990) 0.77
Suboptimal vitamin D status in a population-based study of Asian children: prevalence and relation to allergic diseases and atopy. PLoS One (2014) 0.93
Serum 25-hydroxyvitamin D levels in relation to lung function and exhaled nitric oxide in children. J Pediatr (2014) 0.86
First step towards precision medicine for antithyroid drug-induced agranulocytosis. Lancet Diabetes Endocrinol (2016) 0.80
Exposure to tobacco smoke and childhood rhinitis: a population-based study. Sci Rep (2017) 0.75
A non-threshold region-specific method for detecting rare variants in complex diseases. PLoS One (2017) 0.75
Using propensity score adjustment method in genetic association studies. Comput Biol Chem (2016) 0.75